Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Jan 2026 for Celularity Inc. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Geoffrey M.D. Ling: trading record in brief
Filings by Geoffrey M.D. Ling span 2 companies, the busiest being Celularity Inc and Gyre Therapeutics, Inc. The record holds 9 filings, for trades running from 1 July 2021 to 12 January 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 15 January 2026, the filings show a share grant in Celularity Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Geoffrey M.D. Ling
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
19,231 shares0Class A Common StockSEC:0001493152-26-002424:0
19,231 shares0Class A Common StockSEC:0001493152-26-002303:0
125,000 shares0Class A Common StockSEC:0001493152-25-029617:0
67,416 shares0Class A Common StockSEC:0001493152-25-028780:0
44,379 shares0Class A Common StockSEC:0001493152-25-024631:0
67,416 shares0Class A Common StockSEC:0001493152-25-001099:0
12,855 shares0Common StockSEC:0001209191-22-002485:0
2,858 shares0Common StockSEC:0001209191-21-059433:0
2,713 shares0Common StockSEC:0001209191-21-044691:0
9 of 9 declarations
